v3.25.4
Condensed Consolidated Statements of Cash Flows - USD ($)
 9 Months Ended 10 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2023
Dec. 31, 2024
Cash flows from operating activities:        
Net loss $ (11,973,902) $ (14,185,887) $ (3,793,585) $ (23,753,863)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:        
Stock based compensation 6,082,944 7,034,079 58,536 9,750,511
Finance charges     6,807,702
Synthetic ATM commitment fee     500,000
Change in fair value of common stock make-whole obligation 208,247 272,011
Loss on sale of investments in equity securities 179,805    
Change in fair value of investment in equity securities 700,454 150,994 (18,556) 322,134
Change in fair value of SAFE notes 955,000 212,200 955,000
Loss on write-off of promissory notes and deposit 232,481    
Loss on write-off of deferred transaction cost 30,000    
Change in fair value of warrant liability (1,660,583) 2,753,964 511,342
Change in fair value of convertible notes 471,400 471,400
Change in fair value of sponsor earnout shares (528,000) (1,636,100) (4,076,200)
Depreciation expense 2,317 1,074 6 1,823
SAFE notes issuance costs     466,302
Changes in operating assets and liabilities:        
Prepaid expenses and other assets (53,893) (461,575) (426,497) (47,999)
Accounts payable 58,331 (4,055,728) 310,281 (3,389,540)
Accrued liabilities and other current liabilities 173,039 458,618 208,107 1,955,965
Net cash used in operating activities (6,548,760) (8,514,161) (2,983,206) (9,719,714)
Cash flows from investing activities:        
Capital project costs (3,555,268) (726,102) (1,010,180)
Land acquisition cost (16,619) (100,000) (1,623,946)
Proceeds from sale of investment in equity securities 570,255    
Investment in equity securities     (200,000) (1,600,000)
Investment in other long-term assets (50,000) (50,000)
Purchase of property and equipment (11,155) (1,974) (15,237)
Promissory notes issued (492,000) (492,000)
Net cash used in investing activities (3,001,632) (1,279,257) (301,974) (4,791,363)
Cash flows from financing activities:        
Proceeds from issuance of common stock 1,647,431 87 260,927
Payment of equity issuance costs     (32,601)
Proceeds from early exercise of stock option awards     14,850
Proceeds from investor for issuance of SAFE notes 200,000 5,000,000 200,000
Proceeds from issuance of notes payable to related parties 250,000 1,000,000 2,000,000
Repayment of notes payable to related parties (250,000) (1,000,000)
Proceeds from exercise of warrants 1,561,655 1,561,655
Proceeds from issuance of convertible notes 2,100,000 2,100,000
Deferred transaction costs paid (25,000) (4,134,056) (95,900) (4,167,323)
Payment of issuance costs for SAFE notes to related parties     (435,000)
Repayment of short-term loan from related parties (2,000,000)    
Proceeds from short-term loan 337,244 510,000 80,800 2,060,000
Repayment of short-term loan (1,841,129) (199,170) (7,833) (324,415)
Proceeds from advance received from PIPE investors 125,000 11,639,088 425,000
Proceeds from public offering 10,270,400    
Proceeds from warrant inducement exercises 2,971,040    
Transaction costs associated with public offering and warrant inducement (1,260,226)    
Proceeds from of business combination and issuance of PIPE shares     11,639,088
Repayment of sponsor promissory notes (1,562,834) (1,562,834)
Repurchase of unvested shares (1,593) (6,003) (7,670)
Cash in lieu payment on fractional shares under reverse stock split (345)    
Net cash provided by financing activities 10,222,822 10,108,680 4,557,004 14,151,827
Net (decrease)/ increase in cash 672,430 315,262 1,271,824 (359,250)
Cash at the beginning of the period 912,574 1,271,824 1,271,824
Cash at the end of the period 1,585,004 1,587,086 1,271,824 912,574
Supplemental disclosure for cash flow information:        
Interest paid 146,208 8,814 7,667 16,055
Taxes paid 5,150 3,173
Supplemental disclosure of non-cash investing and financing activities:        
Unpaid deferred transaction costs 3,470,991 909,209 3,354,121
Unpaid amount for repurchase of unvested shares     6,003
Conversion of legacy SAFE notes 64 64
Conversion of legacy convertible notes 26 26
Sponsor earnout share liability 4,608,900 4,076,200
Issuance of common stock to Sponsor 400 400
Net liabilities assumed upon closing of business combination 14,638,315 14,638,215
Issuance of common stock to non-redeeming shareholders 13 13
Unpaid SAFE note issuance costs     31,302
Unpaid capital project costs 478,139 2,310,223
Unpaid land purchase costs     16,619
Commitment and other fees for synthetic ATM     500,000
Unpaid finance charge related to common stock issuance to lenders     567,031
Finance charge related to Equity Kicker     $ 6,200,000
Unpaid pre-acquisition capital project costs 846,385    
Reclass of advances to capital project costs 236,235    
Unpaid public offering issuance cost 615,270    
Unpaid warrant inducement issuance cost 29,000    
Incremental fair value of warrant inducement 2,108,480    
Issuance of common stock to short- term loan holders 6,200,000    
Issuance of common stock to PIPE investors 550,000    
Issuance of common stock to vendor 80,612    
Issuance of common stock under license arrangement $ 343,000